Inclusion Criteria:  Diagnosis of Type2 Diabetes Possess a smart phone (iPhone or Android only) capable of running the smart phone application (App) used in the study; HbA1c level ≥7% and <11%, as determined by the HbA1c measured within the previous 12 months; Willing to use a glucometer for self-monitoring blood glucose while using the study App; Capable of giving informed consent in English, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.  Exclusion Criteria:  Unable to understand, consent to, or comply with the study protocol for any reason, including the inability to read or comprehend English. The behavioral intervention mechanisms, including educational materials and digital tools, are only available in English at this time; Currently taking prandial (mealtime) insulin; Currently experiencing heart failure of New York Heart Association Class IV; Currently experiencing stage 4 or 5 chronic kidney disease; Currently on kidney dialysis (hemo or peritoneal); Currently on the list for an organ transplant or previously received a transplant of any organ; Currently receiving treatment for cancer; For women only: pregnant or lactating or having the intention of becoming pregnant during the time frame of the study; Presumed or confirmed COVID-19 diagnosis within 90 days prior to study enrollment